Location History:
- Morecombe, GB (2013)
- Al Ain, AE (2014 - 2017)
- Doha, QA (2019)
Company Filing History:
4 out of 263 
1 out of 3 Years Active: 2013-2019
Title: The Innovative Contributions of Omar El-Agnaf
Introduction
Omar El-Agnaf is a prominent inventor based in Al Ain, United Arab Emirates. He has made significant contributions to the field of neurodegenerative disease research through his innovative inventions. With a total of 4 patents, El-Agnaf's work focuses on the development of antibodies that can aid in the diagnosis of various neurodegenerative conditions.
Latest Patents
One of his latest patents is titled "Alpha-synuclein antibodies and uses thereof." This invention describes antibodies that exhibit a high affinity for aggregated forms of α-synuclein while maintaining a low affinity for its monomeric forms. These antibodies are particularly useful in diagnosing neurodegenerative diseases, showcasing El-Agnaf's commitment to advancing medical science.
Career Highlights
Throughout his career, Omar El-Agnaf has worked with esteemed institutions such as United Arab Emirates University and Università degli Studi di Perugia. His research has garnered attention for its potential impact on understanding and diagnosing neurodegenerative diseases.
Collaborations
El-Agnaf has collaborated with notable colleagues in his field, including Lucilla Parnetti and Paolo Calabresi. These partnerships have further enriched his research and contributed to the advancement of knowledge in neurodegenerative disease diagnostics.
Conclusion
Omar El-Agnaf's innovative work in developing antibodies for neurodegenerative disease diagnosis highlights his significant contributions to medical research. His patents and collaborations reflect a dedication to improving healthcare outcomes through scientific innovation.